The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Some stimulatory receptors of the innate immune system, such as the NKG2D receptor (also called KLRK1) expressed by natural killer cells and activated CD8(+)T cells, recognize self-molecules that are upregulated in diseased cells by poorly understood mechanisms. Here we show that mouse and human NKG2D ligands are upregulated in non-tumour cell lines by genotoxic stress and stalled DNA replication, conditions known to activate a major DNA damage checkpoint pathway initiated by ATM (ataxia telangiectasia, mutated) or ATR (ATM- and Rad3-related) protein kinases. Ligand upregulation was prevented by pharmacological or genetic inhibition of ATR, ATM or Chk1 (a downstream transducer kinase in the pathway). Furthermore, constitutive ligand expression by a tumour cell line was inhibited by targeting short interfering RNA to ATM, suggesting that ligand expression in established tumour cells, which often harbour genomic irregularities, may be due to chronic activation of the DNA damage response pathway. Thus, the DNA damage response, previously shown to arrest the cell cycle and enhance DNA repair functions, or to trigger apoptosis, may also participate in alerting the immune system to the presence of potentially dangerous cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition, genomic damage—a common cause of cellular senescence—induces expression of the membrane-bound ligands for the major natural killer cell receptor NKG2D (140).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [140]
The cited source says what the claim attributes to it.
In the citing paper
“other evidence indicates that the immune system's recognition of tumour cells might require the continuous activation of the DDR pathway 13”
From The common biology of cancer and ageing (2007) · cites this paper as [13]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Further, DNA damage or activation of oncogenes can induce cellular senescence, through a pathway that relies, in part, on the secretion of pro-inflammatory cytokines such as insulin-like growth factor binding protein-7 (IGFBP7)32 and IL-633, and on the secretion of CXC-chemokine ligand 8 (CXCL8) and other chemokines 33,34, as well as on the expression of the CXCL8 receptor CXC-chemokine receptor 2”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [32]
Experimental — accuracy not yet measuredIn the citing paper
“These findings are consistent with previous studies suggesting that NKG2D ligands are induced by a variety of other stimuli, including E2F transcription factors, PI3 kinase, Ras oncogene signaling, and an activated DNA damage response (Gasser et al., 2005; Tokuyama et al., 2011; Jung et al., 2012).”
From p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells (2013) · cites this paper as Gasser et al., 2005
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: p73α Regulation by Chk1 in Response to DNA Damage
Gonzalez, S., Prives, C., & Cordon-Cardo, C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8161-8171.2003 · Cited by 75
RetractedDNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
Sancar, A., Lindsey-Boltz, L. A., Ünsal-Kaçmaz, K., & Linn, S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073723 · Cited by 3,317
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Cell cycle checkpoint signaling through the ATM and ATR kinases
Abraham, R. T. (2001) · Genes & Development · doi:10.1101/gad.914401 · Cited by 1,966
Chk1 and Chk2 kinases in checkpoint control and cancer
Bartek, J., & Lukas, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00110-7 · Cited by 1,513
Roles of the NKG2D immunoreceptor and its ligands
Raulet, D. H. (2003) · Nature Reviews Immunology · doi:10.1038/nri1199 · Cited by 1,348
Self-citation(1999) · PubMed · Cited by 1,030
ATR disruption leads to chromosomal fragmentation and early embryonic lethality
Brown, E. J., & Baltimore, D. (2000) · Genes & Development · doi:10.1101/gad.14.4.397 · Cited by 951
Self-citation
Cited by
Items 301–400 of 1,000
IL-15 Overcomes Hepatocellular Carcinoma-Induced NK Cell Dysfunction
Easom, N. J. W., Stegmann, K. A., Swadling, L., Pallett, L. J., Burton, A. R., Odera, D., Schmidt, N. M., Huang, W., Fusai, G., Davidson, B. R., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01009 · Cited by 99
“One of the major pathways through which NK cells provide immunosurveillance of tumors is through recognition of DNA damage responseinduced NKG2D-ligands (NKG2D-L) by the activatory receptor, NKG2D (6, 7).”
BackgroundLaezza, C., Pisanti, S., Crescenzi, E., & Bifulco, M. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.09.074 · Cited by 99
“To ascertain whether Chk1 phosphorylation mediates Met-F-AEA induced Cdc25A degradation, we treated MDA-MB-231 cells with Met-F-AEA in presence of a Chk1 inhibitor, staurosporine [25], at 8 nM for 24 h.”
MethodMultiplicity and plasticity of natural killer cell signaling pathways
Chiesa, S., Mingueneau, M., Fuseri, N., Malissen, B., Raulet, D. H., Malissen, M., Vivier, E., & Tomasello, E. (2006) · Blood · doi:10.1182/blood-2005-08-3504 · Cited by 89
“The cell surface expression of these ligands is often the consequence of cellular stress, such as DNA damage.(13,14) NKG2D ligands include MIC (MHC class I chain related) and ULBP (UL-16 binding protein) molecules in humans as well as Rae (Retinoic acid early inducible 1), H60 and MULT-1 (Murine UL16-Binding Protein-L…”
BackgroundSelf-citationCellular senescence: from growth arrest to immunogenic conversion
Burton, D. G. A., & Faragher, R. (2015) · AGE · doi:10.1007/s11357-015-9764-2 · Cited by 112
DICER1 and microRNA regulation in post-traumatic stress disorder with comorbid depression
Wingo, A. P., Almli, L. M., Stevens, J. S., Klengel, T., Uddin, M., Li, Y., Bustamante, A. C., Lori, A., Koen, N., Stein, D. J., et al. (2015) · Nature Communications · doi:10.1038/ncomms10106 · Cited by 98
Soriani, A., Iannitto, M. L., Ricci, B., Fionda, C., Malgarini, G., Morrone, S., Peruzzi, G., Ricciardi, M. R., Petrucci, M. T., Cippitelli, M., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400271 · Cited by 104
“(2) demonstrated that NKG2D ligand upregulation is prevented by pharmacologic or genetic inhibition of ATM/ATR or Chk1 with no requirement for p53.”
BackgroundPeng, Y., Zhang, J., Liang, W., Tu, M., Lu, Z., Wei, J., Jiang, K., Gao, W., Wu, J., Xu, Z., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-738 · Cited by 98
“For example, MHC class I polypeptide-related sequence A/B (MICA/MICB) and UL16-binding protein (ULBP) bind to NKG2D [31]; whereas cellular heparin or heparin sulfate proteoglycans bind to NCRs [32].”
BackgroundKumar, V., Lo, P. H. Y., Sawai, H., Kato, N., Takahashi, A., Deng, Z., Urabe, Y., Mbarek, H., Tokunaga, K., Tanaka, Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044743 · Cited by 105
“considered as a stress marker of gastrointestinal epithelial cells because of its induced expression by several external stimuli such as heat, DNA damage, and viral infections [31,32,33,34].”
BackgroundUpshaw, J. L., & Leibson, P. J. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.03.001 · Cited by 114
Iannello, A., Débbeche, O., Samarani, S., & Ahmad, A. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0907650 · Cited by 98
“, heat shock, hypoxia, inflammation, TNF- , or IL-8), do not induce expression of NKG2D ligands [104–107].”
BackgroundRegulation of NKG2D-Dependent NK Cell Functions: The Yin and the Yang of Receptor Endocytosis
Molfetta, R., Quatrini, L., Santoni, A., & Paolini, R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081677 · Cited by 103
“NKG2DLs are absent on the surface of the vast majority of healthy tissues but are up-regulated under stressing conditions, including mitosis, viral infection and cancer by several pathways mainly acting at transcriptional and post-transcriptional levels [3,19,20].”
BackgroundElahi, R., Heydari, A. H., Hadiloo, K., & Esmaeilzadeh, A. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10246-3 · Cited by 101
Posttranslational regulation of the NKG2D ligand Mult1 in response to cell stress
Nice, T. J., Coscoy, L., & Raulet, D. H. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081335 · Cited by 98
Self-citationInterfaces between cellular responses to DNA damage and cancer immunotherapy
Pilger, D., Seymour, L. W., & Jackson, S. P. (2021) · Genes & Development · doi:10.1101/gad.348314.121 · Cited by 95
“Notably, theDDRparticipates in this process, since DNA damage induction in tumors cells results in up-regulation of ligands for the receptors NKG2D and DNAM-1, therefore stimulating cytotoxicity of NK and CD8 T cells in addition to IFN-γ secretion (Gasser et al. 2005; Croxford et al. 2013).”
BackgroundDuan, X., Deng, L., Chen, X., Lu, Y., Zhang, Q., Zhang, K., Hu, Y., Zeng, J., & Sun, W. (2010) · Medical Oncology · doi:10.1007/s12032-010-9480-9 · Cited by 97
“via DNA damage pathway [23].”
MICA polymorphism: biology and importance in cancer
Chen, D., & Gyllensten, U. B. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu215 · Cited by 96
“However, it is upregulated or expressed de novo in stressed conditions, such as during viral and bacterial infections (7,11,12), heat shock (9), DNA damage response (13), oncogenic transformation (5,6) and in autoimmune conditions (14).”
BackgroundCytokine-driven regulation of NK cell functions in tumor immunity: Role of the MICA-NKG2D system
Zwirner, N. W., Fuertes, M. B., Girart, M. V., Domaica, C. I., & Rossi, L. E. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.01.013 · Cited by 100
“[47] Gasser S, Orsulic S, Brown EJ, Raulet DH.”
BackgroundInfluentialChimeric NKG2D Receptor–Bearing T Cells as Immunotherapy for Ovarian Cancer
Barber, A., Zhang, T., DeMars, L. R., Conejo-Garcia, J. R., Roby, K. F., & Sentman, C. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4047 · Cited by 95
“It has been shown that activation of DNA damage repair pathways induces the expression of NKG2D ligands (33).”
Cao, G., Wang, J., Zheng, X., Wei, H., Tian, Z., & Sun, R. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.674010 · Cited by 99
“For example, the DNA damage response induced by irradiation and chemotherapeutic reagents is reported to up-regulate the expression of NKG2D ligands on tumor cells (11).”
BackgroundImmune Activation Resulting From NKG2D/Ligand Interaction Promotes Atherosclerosis
Xia, M., Guerra, N., Sukhova, G. K., Yang, K., Miller, C. K., Shi, G., Raulet, D. H., & Xiong, N. (2011) · Circulation · doi:10.1161/circulationaha.111.034850 · Cited by 116
Self-citationHervieu, A., Rébé, C., Végran, F., Chalmin, F., Bruchard, M., Vabres, P., Apétoh, L., Ghiringhelli, F., & Mignot, G. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.273 · Cited by 97
“Platinum derivates were also shown to stimulate the expression of ligands for NKG2D, an natural killer (NK) cell–activating receptor, which determines the innate immune response against leukemic tumors (Gasser et al., 2005).”
BackgroundTietze, J. K., Wilkins, D. E. C., Sckisel, G. D., Bouchlaka, M. N., Alderson, K. L., Weiss, J. M., Ames, E., Bruhn, K. W., Craft, N., Wiltrout, R. H., et al. (2012) · Blood · doi:10.1182/blood-2011-07-369736 · Cited by 94
NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy
Malmberg, K., Bryceson, Y. T., Carlsten, M., Andersson, S., Björklund, A. T., Björkström, N. K., Baumann, B. C., Fauriat, C., Alici, E., Dilber, M. S., et al. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0492-7 · Cited by 98
“NKG2D are up-regulated by genotoxic stress and stalled DNA replication, through activation of major DNA damage checkpoint pathways initiated by ATM or ATR protein kinases [40, 41].”
The role of senescent T cells in immunopathology
Covre, L. P., De Maeyer, R. P. H., Gomes, D. C. O., & Akbar, A. N. (2020) · Aging Cell · doi:10.1111/acel.13272 · Cited by 93
“However, the inflammation in the skin, induced by the interaction between infected macrophages and the infiltrating T cells, induces the expression of stress ligands including those that bind to NK receptors by the surrounding stroma (Gasser et al., 2005; Groh et al., 2001; Molinero et al., 2004).”
BackgroundIPSC-derived CAR-NK cells for cancer immunotherapy
Lin, X., Sun, Y., Dong, X., Liu, Z., Sugimura, R., & Xie, G. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115123 · Cited by 93
Signal Transduction: How Rad53 Kinase Is Activated
Pellicioli, A., & Foiani, M. (2005) · Current Biology · doi:10.1016/j.cub.2005.08.057 · Cited by 108
DNA damage: a trigger of innate immunity but a requirement for adaptive immune homeostasis
Xu, Y. (2006) · Nature reviews. Immunology · doi:10.1038/nri1804 · Cited by 108
Treatment of multiple myeloma with adoptively transferred chimeric NKG2D receptor-expressing T cells
Barber, A., Meehan, K. R., & Sentman, C. L. (2011) · Gene Therapy · doi:10.1038/gt.2010.174 · Cited by 91
She, M., Xinqing, N., Chen, X., Li, J., Zhou, M., He, Y., Le, Y., & Guo, K. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.12.017 · Cited by 92
The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease
Stojanovic, A., Correia, M. P., & Cerwenka, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00827 · Cited by 93
“This is not surprising, as induction of NKG2DLs was correlated with cell proliferation (65) and DNA damage (30, 31), which might occur during effector responses in tissues.”
BackgroundIsernhagen, A., Malzahn, D., Viktorova, E. V., Elsner, L., Monecke, S., von Bonin, F., Kilisch, M., Wermuth, J. M., Walther, N., Balavarca, Y., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201505246 · Cited by 91
“It is constitutively expressed on a few cell types, such as gastrointestinal epithelium (Groh et al , 1996) but becomes induced by cellular and genotoxic stress (Groh et al , 1996; Gasser et al , 2005) in malignant or virus-infected cells (Champsaur & Lanier, 2010; Raulet et al , 2013).”
Fionda, C., Soriani, A., Malgarini, G., Iannitto, M. L., Santoni, A., & Cippitelli, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901797 · Cited by 95
“These stress-inducible proteins include the NKG2D ligands (42), DNAM-1 ligands (10), together with the membrane expression and release of the HSP-70, that can trigger and redirect cytolytic and migratory capacity of NK cells toward tumors (43).”
BackgroundTakada, A., Yoshida, S., Kajikawa, M., Miyatake, Y., Tomaru, U., Sakai, M., Chiba, H., Maenaka, K., Kohda, D., Fugo, K., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1678 · Cited by 89
“The ligands for NKG2D are usually expressed only poorly or not at all by normal cells, but their expression is up-regulated in response to cellular distress such as transformation (15), infection (16, 17), heat shock (18), and DNA damage (19).”
BackgroundFrom cancer immunosurveillance to cancer immunotherapy
Stagg, J., Johnstone, R. W., & Smyth, M. J. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00566.x · Cited by 107
“Studies from the laboratory of David Raulet (11, 49) have demonstrated that DNA-damaging agents can induce the expression of NKG2D ligands in a mechanism dependent on the DNA-damage response.”
BackgroundOrr, M. T., Sun, J. C.-Y., Hesslein, D. G. T., Arase, H., Phillips, J. H., Takai, T., & Lanier, L. L. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20090168 · Cited by 91
Beyond Stressed Self: Evidence for NKG2D Ligand Expression on Healthy Cells
Eagle, R. A., Jafferji, I., & Barrow, A. D. (2009) · Current Immunology Reviews · doi:10.2174/157339509787314369 · Cited by 101
“Boissel N, Rea D, Tieng V, et al. BCR/ABL oncogene directly controls MHC class I chainrelated molecule A expression in chronic myelogenous leukemia.”
BackgroundThe Unique Properties of Human NK Cells in the Uterine Mucosa
Manaster, I., & Mandelboim, O. (2007) · Placenta · doi:10.1016/j.placenta.2007.10.006 · Cited by 91
ITAM-based signaling beyond the adaptive immune response
Fodor, S., Jakus, Z., & Mócsai, A. (2005) · Immunology Letters · doi:10.1016/j.imlet.2005.11.001 · Cited by 102
The breast tumor microenvironment alters the phenotype and function of natural killer cells
Krneta, T., Gillgrass, A. E., Chew, M. V., & Ashkar, A. A. (2015) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.42 · Cited by 90
MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer
Cho, H., Chung, J., Kim, S., Braunschweig, T. A., Kang, T. H., Kim, J., Chung, E. J., Hewitt, S. M., & Kim, J.-H. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-957 · Cited by 95
“Lastly, some stimuli, such as DNA damage response, have been reported to result in expression of all NKG2DLs tested, while other stimuli have been shown to induce expression of other specific NKG2DLs [26].”
BackgroundNKG2D and cytotoxic effector function in tumor immune surveillance
Hayakawa, Y., & Smyth, M. J. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.03.005 · Cited by 106
Tumor stress, cell death and the ensuing immune response
Ullrich, E., Bonmort, M., Mignot, G., Kroemer, G., & Zitvogel, L. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402266 · Cited by 103
“The DNA damage response also induces expression of NKG2D ligands in an ATM or ATR protein kinase-dependent way.(49) NKG2D is an activating receptor involved in tumor immunosurveillance.”
BackgroundExpanded and armed natural killer cells for cancer treatment
Shimasaki, N., Coustan‐Smith, E., Kamiya, T., & Campana, D. (2016) · Cytotherapy · doi:10.1016/j.jcyt.2016.06.013 · Cited by 96
“One of the activating receptors upregulated in expanded NK cells is NKG2D, a type II transmembraneanchored C-type lectin-like protein that binds several ligands overexpressed on tumor cells, including MHC class I chain-related A (MICA), MICB and several UL16-binding proteins (ULBPs) [65–68].”
BackgroundPrerequisites for the Antitumor Vaccine-Like Effect of Chemotherapy and Radiotherapy
Hannani, D., Sistigu, A., Kepp, O., Galluzzi, L., Kroemer, G., & Zitvogel, L. (2011) · The Cancer Journal · doi:10.1097/ppo.0b013e3182325d4d · Cited by 91
NK cell-based therapeutics for lung cancer
Pockley, A. G., Vaupel, P., & Multhoff, G. (2020) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2020.1688298 · Cited by 86
Effects of Radiation on the Tumor Microenvironment
Monjazeb, A. M., Schalper, K. A., Villarroel‐Espíndola, F., Nguyen, A. T., Shiao, S. L., & Young, K. H. (2020) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2019.12.004 · Cited by 93
Function and Molecular Mechanism of the DNA Damage Response in Immunity and Cancer Immunotherapy
Ye, Z., Shi, Y., Lees‐Miller, S. P., & Tainer, J. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.797880 · Cited by 94
“Importantly, non-self nucleic acids are the most well-characterized stimuli for the innate immune response (32, 33); furthermore, endogenous cytosolic DNA released from the nucleus or mitochondria stimulates the innate immune system.”
BackgroundCrozat, K., Vivier, E., & Dalod, M. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00736.x · Cited by 86
Huergo-Zapico, L., Acebes‐Huerta, A., González, A. P., Contesti, J., González-García, E., Páyer, Á. R., Villa-Álvarez, M., Fernández-Guizán, A., López‐Soto, A., & Gonzalez, S. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108326 · Cited by 88
“NKG2D is the receptor for MHC class I-related chain A and B (MICA/B) and UL16-binding proteins 1–6 (ULBP1-6), which are restrictedly expressed in benign cells, but are up-regulated in stressed and transformed cells, triggering a potent anti-tumour immune response [10–12].”
BackgroundImmune recognition of irradiated cancer cells
Wennerberg, E., Vanpouille‐Box, C., Bornstein, S., Yamazaki, T., Demaria, S., & Galluzzi, L. (2017) · Immunological Reviews · doi:10.1111/imr.12568 · Cited by 93
An integrated view of the regulation of NKG2D ligands
Stern‐Ginossar, N., & Mandelboim, O. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03147.x · Cited by 82
New strategies to treat AML: novel insights into AML survival pathways and combination therapies
Nair, R., Salinas-Illarena, A., & Baldauf, H. (2020) · Leukemia · doi:10.1038/s41375-020-01069-1 · Cited by 94
“Paczulla et al. reported that the PARP1-dependent downregulation of NKG2DL in leukemic stem cells leads to their immune evasion by making themselves unrecognizable by NK cells and T cells that express the receptors on their surface [54].”
BackgroundInfluentialJinushi, M., Hodi, F. S., & Dranoff, G. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00618.x · Cited by 86
“MICA normally displays restricted expression in some gastrointestinal and thymic epithelial cells, but it may be induced during transformation as part of a damage response triggered by DNA double-strand breaks (134, 135).”
BackgroundKamran, N., Takai, Y., Miyoshi, J., Biswas, S. K., Wong, J. S. B., & Gasser, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054406 · Cited by 92
“Transduction of cells was performed as described before [63].”
MethodSelf-citationChemoImmunoModulation: Immune Regulation by the Antineoplastic Chemotherapeutic Agents
Shurin, M. R., Naiditch, H., Gutkin, D. W., Umansky, V., & Shurin, G. V. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800099785 · Cited by 98
Gonzalez, V. D., Huang, Y.-W., Delgado‐González, A., Chen, S.-Y., Donoso, K., Sachs, K., Gentles, A. J., Allard, G. M., Kolahi, K. S., Howitt, B. E., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109632 · Cited by 85
“Activation of the DNA damage response with genotoxic agents increases the expression of ligands for NKG2D and DNAM1, thereby making a stressed cell more susceptible to NK cell killing (Cerboni et al., 2014; Gasser et al., 2005).”
BackgroundInfluentialWu, X., Yi, T., Hou, J., Meng, X., & Shi, J. (2012) · Neoplasia · doi:10.1593/neo.121236 · Cited by 85
Eissmann, P., Evans, J. H., Mehrabi, M., Rose, E. L., Nedvetzki, S., & Davis, D. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903985 · Cited by 79
“the DNA damage pathway kinases ataxia telangiectasia mutated (ATM)/ataxia telangiectasia and Rad3 related (ATR) and their downstream targets CHK-1 and -2 (15).”
BackgroundInfluentialBuilding immunity to cancer with radiation therapy
Haikerwal, S. J., Hagekyriakou, J., MacManus, M. P., Martin, O. A., & Haynes, N. M. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.01.009 · Cited by 90
“Retinoic acid early inducible (RAE)-1] [52] and heat shock proteins [e.”
BackgroundPizzi, S., Sertic, S., Orcesi, S., Cereda, C., Bianchi, M., Jackson, A. P., Lazzaro, F., Plevani, P., & Muzi-Falconi, M. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddu485 · Cited by 81
Immunobiology and Conflicting Roles of the Human NKG2D Lymphocyte Receptor and Its Ligands in Cancer
El‐Gazzar, A., Groh, V., & Spies, T. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301071 · Cited by 85
“DNA damaging agents and replication inhibitors can induce expression of ULBP1–3 and mouse NKG2D ligands (4, 25).”
BackgroundCell death in head and neck cancer pathogenesis and treatment
Raudenská, M., Balvan, J., & Masařík, M. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03474-5 · Cited by 87
Memory‐like responses of natural killer cells
Cooper, M. A., & Yokoyama, W. M. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2010.00891.x · Cited by 94
Intrinsic sensor of oncogenic transformation induces a signal for innate immunosurveillance
Unni, A. M., Bondar, T., & Medzhitov, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701675105 · Cited by 80
Chretien, A.-S., Le Roy, A., Vey, N., Prebet, T., Blaise, D., Fauriat, C., & Olive, D. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00122 · Cited by 79
Targeting the DNA Damage Response for Cancer Therapy by Inhibiting the Kinase Wee1
Bukhari, A. B., Chan, G. K. T., & Gamper, A. M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.828684 · Cited by 83
“Furthermore, activation of the apicalDDRkinasesATMandATRcan also lead to upregulation of PD-L1 (via the STAT1 and STAT3 pathway) (154) and natural killer group 2D (NKG2D) ligands (155, 156).”
BackgroundTranscriptional Regulation of ULBP1, a Human Ligand of the NKG2D Receptor
López-Soto, A., Quiñones-Lombraña, A., López-Arbesú, R., López-Larrea, C., & González, S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604868200 · Cited by 78
Mechanisms of Tumor and Viral Immune Escape from Natural Killer Cell-Mediated Surveillance
Groth, A., Klöß, S., von Strandmann, E. P., Koehl, U., & Koch, J. (2011) · Journal of Innate Immunity · doi:10.1159/000327014 · Cited by 95
“genotoxic stress and stalled DNA replication, which activate a major DNA damage checkpoint controlled by ATM or ATR protein kinases [”
McCann, F. E., Eissmann, P., Önfelt, B., Leung, R., & Davis, D. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3418 · Cited by 90
“Most recently, NKG2D ligands were shown to be induced by signal cascades involved in the DNA damage pathway (14).”
BackgroundBanerjee, P., Feuer, G., & Barker, E. (2007) · Journal of Virology · doi:10.1128/jvi.00887-07 · Cited by 77
DAMP—Induced Allograft and Tumor Rejection: The Circle Is Closing
Land, W. G., Agostinis, P., Gasser, S., Garg, A. D., & Linkermann, A. (2016) · American Journal of Transplantation · doi:10.1111/ajt.14012 · Cited by 85
Self-citationBurkard, M., Leischner, C., Lauer, U. M., Busch, C., Venturelli, S., & Frank, J. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.01.006 · Cited by 83
“trichostatin A, valproate, panobinostat, and vorinostat) seem to enhance susceptibility of malignant target cells by increasing the expression of NKG2D ligands on the surface of tumor cells (39, 43, 45-49), even though valproate and vorinostat were shown to suppress cytotoxicity from IL-2 activated NK cells, which was…”
Activating NK‐cell receptors co‐stimulate CD4+CD28− T cells in patients with rheumatoid arthritis
Fasth, A. E. R., Björkström, N. K., Anthoni, M., Malmberg, K., & Malmström, V. (2010) · European Journal of Immunology · doi:10.1002/eji.200939399 · Cited by 79
Sheehan, C. S., & D’Souza‐Schorey, C. (2019) · Journal of Cell Science · doi:10.1242/jcs.235085 · Cited by 81
“In the case of cancer, genotoxic stress likewise can induce the expression of NKG2D ligands, making tumor cells vulnerable to targeting by immune cells (Gasser et al., 2005).”
BackgroundBrooks, P. J., Cheng, T., & Cooper, L. D. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.01.017 · Cited by 90
“The alternative model involves ATM signaling via the NKG2D receptor that is expressed by Granzyme Asecreting immune cells [64].”
BackgroundZhang, C., Wang, Y., Zhou, Z., Zhang, J., & Tian, Z. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0645-8 · Cited by 83
“Although the mechanisms that regulate expression of NKG2D ligands are not well understood, it has been demonstrated that they can be upregulated by DNA damage, heat shock, and oxidative stress [4, 5, 7–9].”
BackgroundChua, A. C. L., Hodson, L. J., Moldenhauer, L. M., Robertson, S. A., & Ingman, W. V. (2010) · Development · doi:10.1242/dev.059261 · Cited by 79
“…proliferation and differentiation of mammary epithelial cells, the phagocytosis of apoptotic cell bodies, and in the tissue remodelling events that occur during mammary gland development (Cecchini et al., 1994; Gouon Evans et al., 2000; Pollard and Hennighausen, 1994; Van Nguyen and Pollard, 2002).”
BackgroundInfluentialKamrava, M. R., Bernstein, M. B., Camphausen, K. A., & Hodge, J. W. (2009) · Molecular BioSystems · doi:10.1039/b911313b · Cited by 84
Stabile, H., Nisti, P., Morrone, S., Pagliara, D., Bertaina, A., Locatelli, F., Santoni, A., & Gismondi, A. (2015) · Haematologica · doi:10.3324/haematol.2014.116053 · Cited by 80
“that recognizes self proteins up-regulated on stressed or damaged cells.(15) The expression of both activating and inhibitory”
BackgroundZingoni, A., Ardolino, M., Santoni, A., & Cerboni, C. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00408 · Cited by 81
“Gasser et al. (2005) demonstrated that murine and human NKG2DLs are up-regulated in fibroblasts by genotoxic stress and stalled DNA replication, conditions known to activate the DNA damage response (DDR) initiated by ATM (ataxia-telangiectasia, mutated) or ATR (ATM/Rad3-related) kinases.”
Chimeric NKG2D receptor–expressing T cells as an immunotherapy for multiple myeloma
Barber, A., Zhang, T., Megli, C., Wu, J., Meehan, K. R., & Sentman, C. L. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.04.010 · Cited by 78
“While NKG2D ligands are not usually expressed on most healthy tissues, ligand expression can be upregulated upon DNA damage, infection, or transformation of cells [13,22,23].”
BackgroundPan, J., Shen, J., Si, W., Du, C., Chen, D., Xu, L., Yao, M., Fu, P., & Fan, W. (2017) · Oncotarget · doi:10.18632/oncotarget.19445 · Cited by 79
“Numerous signals and pathways have been identified as regulators of NKG2DLs, including the ATM (ataxia-telangiectasia, mutated) and ATR (ATM and Rad3-related) pathways, the NF-κB pathway, heat shock factor-1, Sp-family transcription factors and the ERK signaling pathway [4, 6, 30-32].”
BackgroundBouchet, A., Sakakini, N., Atifi, M. E., Clec’h, C. L., Bräuer‐Krisch, E., Moisan, A., Deman, P., Rihet, P., Duc, G. L., & Pelletier, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081874 · Cited by 81
“[46] reported that DNA damage can elicit a response of immune system, and in particular of innate compartment (macrophages).”
BackgroundATM‐dependent DNA damage surveillance in T‐cell development and leukemogenesis: the DSB connection
Matei, I. R., Guidos, C. J., & Danska, J. S. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00361.x · Cited by 72
“cellular processes, such as cell growth, survival, anti-tumor immune surveillance, and transcriptional control, have only begun to be explored (75, 76).”
BackgroundSaghire, H. E., Thierens, H. M., Monsieurs, P., Michaux, A., Vandevoorde, C., & Baatout, S. (2013) · International Journal of Radiation Biology · doi:10.3109/09553002.2013.782448 · Cited by 80
“Previously, natural killer group 2 member D (NKG2D) receptor, one of the NOD-like receptors, was shown to be activated in response to DNA damage, including IR (Gasser et al. 2005).”
BackgroundInnate Immune Recognition and Suppression of Tumors
Hayakawa, Y., & Smyth, M. J. (2006) · Advances in cancer research · doi:10.1016/s0065-230x(06)95008-8 · Cited by 83
Liu, S. Q., Sun, X., Luo, J., Zhu, H., Yang, X., Guo, Q., Song, Y., & Sun, X. (2015) · PubMed Central · Cited by 91
Proteasome Regulation of ULBP1 Transcription
Butler, J. E., Moore, M. B., Presnell, S. R., Chan, H.-W., Chalupny, N. J., & Lutz, C. T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801214 · Cited by 69
“found that NKG2D ligands could be up-regulated in p53 knockout cells, but they did not rule out a role for p53 family members, p63 and p73, that also are targets of ATM/ATR signaling and MDM2 regulation (47, 76).”
InfluentialBorchers, M. T., Wesselkamper, S. C., Curull, V., Ramírez-Sarmiento, A., Sánchez‐Font, A., García‐Aymerich, J., Coronell, C., Lloreta, J., Agustí, A. G. N., Gea, J., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci34462 · Cited by 77
“Along these lines, NKG2D ligand induction has previously been reported in response to toll-like receptor stimulation (51) and DNA damage (10).”
BackgroundDecreased Dicer expression elicits DNA damage and up-regulation of MICA and MICB
Tang, K.-F., Ren, H., Cao, J., Zeng, G.-L., Xie, J., Chen, M., Wang, L., & He, C.-X. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200801169 · Cited by 73
“…human NKG2D ligands are up-regulated in nontumor cell lines by genotoxic stress and stalled DNA replication, conditions known to activate a major DNA damage checkpoint pathway initiated by ataxia telangiectasia mutated (ATM) or ATM- and Rad3-related (ATR) protein kinases ( Gasser et al., 2005 ).”
BackgroundInfluentialRoutes, J. M., Ryan, S., Morris, K. R., Takaki, R., Cerwenka, A., & Lanier, L. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050240 · Cited by 82
“NKG2D ligands are an attractive candidate because they are up-regulated by a variety of cellular stresses, including viral infection (5, 6) or conditions promoting DNA damage (7).”
BackgroundCombining targeted DNA repair inhibition and immune-oncology approaches for enhanced tumor control
Concannon, K., Morris, B. B., Gay, C. M., & Byers, L. A. (2023) · Molecular Cell · doi:10.1016/j.molcel.2022.12.031 · Cited by 81
Xu, X., Rao, G. S., Groh, V., Spies, T., Gattuso, P., Kaufman, H. L., Plate, J., & Prinz, R. A. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-194 · Cited by 71
“Activation of the DNA damage pathway leads to increased expression of NKG2D ligands in several murine tumor cell lines [34].”
BackgroundReplicative stress, stem cells and aging
Ruzankina, Y., Asare, A., & Brown, E. J. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.03.009 · Cited by 82
“This response is dependent on ATR and ATM and independent of p53 (Gasser et al., 2005).”
Self-citationAndresen, L. O., Skovbakke, S. L., Persson, G., Hagemann-Jensen, M., Hansen, K. A., Jensen, H., & Skov, S. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1004085 · Cited by 72
Nanbakhsh, A., Pochon, C., Mallavialle, A., Amsellem, S., Bourhis, J. H., & Chouaïb, S. (2014) · Blood · doi:10.1182/blood-2013-11-536219 · Cited by 75
“Various molecular pathways, including extracellular signal-regulated kinase (ERK), AKT, p53, and signal transducer and activator of transcription 3 have been reported to play a regulatory, both at the transcriptional or posttranscriptional level.(38-48) In this study, we investigated the molecular basis of cytarabine…”
BackgroundLópez-Cobo, S., Pieper, N., Campos-Silva, C., García-Cuesta, E. M., Reyburn, H. T., Paschen, A., & Valés-Gómez, M. (2018) · OncoImmunology · doi:10.1080/2162402x.2017.1392426 · Cited by 71
“However, NKG2D-L upregulation can also be ATM/ATR dependent in response to DNA-damage.(47) although this route does not seem to be involved in the expression of ligands in cells under other stresses.”
BackgroundPARP mediated DNA damage response, genomic stability and immune responses
Zong, C., Zhu, T., He, J., Huang, R., Jia, R., & Shen, J. (2022) · International Journal of Cancer · doi:10.1002/ijc.33918 · Cited by 74
Searching for “signal 2”: costimulation requirements of γδ T cells
Ribot, J. C., deBarros, A., & Silva‐Santos, B. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0698-2 · Cited by 76
“NKG2D ligands are induced in response to cellular stress, for example, downstream of the DNA-damage response pathway in tumour cells [80, 81].”
BackgroundChen, C.-S., Doloff, J. C., & Waxman, D. J. (2014) · Neoplasia · doi:10.1593/neo.131910 · Cited by 73
“[38] Gasser S, Orsulic S, Brown EJ, and Raulet DH (2005).”
Background
Metadata
- Authors
- Gasser, S., Orsulic, S., Brown, E. J., & Raulet, D. H.
- Affiliations
- University of California, Berkeley (US)
- University of Pennsylvania (US)
- Corresponding author
- Raulet, David H.
- Venue
- Nature
- Published
- 2005-07-03
- Volume
- 436
- Issue
- 7054
- Pages
- 1186-1190
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC1352168
- OpenAlex
- W1969464492
- Cited by
- 1,308
- References
- 28
- Citations by year
- 2026: 23 · 2025: 39 · 2024: 26 · 2023: 51 · 2022: 57 · 2021: 60 · 2020: 72 · 2019: 62 · 2018: 62 · 2017: 64 · 2016: 63 · 2015: 71 · 2014: 85 · 2013: 74 · 2012: 68
- FWCI
- 28.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Prostate Cancer Foundation
- National Institutes of Health
- National Cancer Institute (R01CA093678)
- National Institute of Allergy and Infectious Diseases (R01AI039642)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- NKG2D, NKG2D ligands, DNA damage response, innate immunity, ATM kinase, ATR kinase, Chk1, genotoxic stress, natural killer cells, CD8+ T cells, cancer cell lines, siRNA
- MeSH terms
- Checkpoint Kinase 1, Animals, Cell Transformation, Neoplastic, DNA Damage, DNA Replication, Fibroblasts, Humans, Immune System, Immunity, Innate, Kinetics, Ligands, Mice, Inbred C57BL, Phosphorylation, Protein Kinases, Receptors, Immunologic, Up-Regulation, Aphidicolin, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Cell Line, Tumor, Mice, Receptors, Natural Killer Cell, NK Cell Lectin-Like Receptor Subfamily K, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.